References
- EbriAKuperHWednerSCost-effectiveness of cycloplegic agents: results of a randomized controlled trial in Nigerian childrenInvest Ophthalmol Vis Sci20074831025103117325142
- StolzarIHA new group of cycloplegic drugsAm J Ophthalmol195336111011213016722
- LovasikJVPharmacokinetics of topically applied cyclopentolate HCl and tropicamideAm J Optom Physiol Opt198663107878033777109
- MirandaMNResidual accommodation. A comparison between cyclopentolate 1 per cent and a combination of cyclopentolate 1 per cent and tropicamaide 1 per centArch Ophthalmol19728755155175028092
- EgashiraSMKishLLTwelkerJDComparison of cyclopentolate versus tropicamide cycloplegia in childrenOptom Vis Sci19937012101910268115124
- MannyREFernKDZervasHJ1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative responseOptom Vis Sci19937086516658414387
- LinLLShihYFHsiaoCHThe cycloplegic effects of cyclopentolate and tropicamide on myopic childrenJ Ocul Pharmacol Ther19981443313359715436
- WangXMaLWangLResearch of cyclopentolate 1% on the effect of cycloplegia for Chinese hyperopic childrenZhonghua Yan Ke Za Zhi201114498999422336064
- BagheriAGivradSYazdaniSOptimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trialEur J Ophthalmol200717329430017534806
- MohanKSharmaAOptimal dosage of cyclopentolate 1% for cycloplegic refraction in hypermetropes with brown iridesIndian J Ophthalmol201159651451622011504
- FanDSRaoSKNgJSComparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented iridesClin Experiment Ophthalmol200432546246715498055